CCL5 and neoplasm: First, hypoxia‐triggered release of chemoattractants (i.e., CCL2, CCL5, CXCL12, CSF‐1, and VEGF) from tumor cells and non‐tumor cells to enhance TAMs precursor monocytes recruitment.